உலகளாவிய மருத்துவ வாழ்க்கைத்தொழில்கள் தலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலகளாவிய மருத்துவ வாழ்க்கைத்தொழில்கள் தலை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலகளாவிய மருத்துவ வாழ்க்கைத்தொழில்கள் தலை Today - Breaking & Trending Today

Pyramid Biosciences Announces Leadership Team Expansion

Published: Apr 14, 2021

Jeffrey Wasserman, JD, named General Counsel

WALTHAM, Mass. (BUSINESS WIRE) Pyramid Biosciences, Inc., a Boston-based, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer and other serious diseases, today announced two new appointments to the leadership team.
Brian Lestini, MD, PhD, has joined the company as Chief Medical Officer, where he will oversee the advancement and expansion of the Company s clinical pipeline. Dr. Lestini joins the Company from Bristol-Myers Squibb (NYSE: BMY), where he most recently was Vice President and Development Leader for the relatlimab (anti-LAG3) checkpoint inhibitor program. In this capacity, Dr. Lestini oversaw the development and commercialization strategy for this novel immune-oncology agent across a wide range of tumors. Dr. Lestini brings over a decade of early- and late-stage clinical development leadership experience i ....

New York , United States , Jeffrey Wasserman , Curcio Mirzaian Sirot , Morgan Lewis , Brian Lestini , Kollol Pal , Bristol Myers Squibb , Mayer Brown , Global Medical Affairs Head , Development Leader , Triax Pharmaceuticals , Seton Hall University School Of Law , Tulane University , Pyramid Biosciences Inc , Case Western Reserve University , Chief Medical Officer , Vice President , Hoffmann La Roche , Pyramid Biosciences , Juris Doctorate , Seton Hall University School , Jordan Leef , Pyramid Bioscience , Yramid Biosciences Announces Leadership Team Expansion , புதியது யார்க் ,

DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor and positive impact of reference anti-HER2 treatment on overall survival

(1)
Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 10, 2020 /PRNewswire/ Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, announced today new data from the DETECT study program. These data focused on women with HER2 negative metastatic breast cancer (MBC) based on primary tumor biopsy, and HER2
+ CTCs. The results of this large program demonstrate that screening for HER2+ CTCs, in the blood samples of these patients, is an important tool to guide therapy decisions and improve patient outcomes. Furthermore, the randomized DETECT III phase III study, discussed in a poster spotlight session during the 2020 San Antonio Breast Cancer Symposium, shows that adding reference HER2 targeted TKI (tyrosine kinase inhibitor) ....

San Antonio , United States , Cecilia Simonelli , Kostenloser Wertpapierhandel , Tanjan Fehm , Linda Pavy , Heinrich Heine University , Head Of The Department Gynecology Obstetrics , Us Food Drug Administration , China National Medical Products Administration , Research Use , Menarini Group , Antonio Breast Cancer Symposium , Silicon Biosystems , Menarini Silicon Biosystem , Global Medical Affairs Head , Menarini Silicon , Circulating Tumor Cell , Drug Administration , Metastatic Breast , Tumor Cell Kit , Phenotyping Reagent , Huntingdon Valley , சான் அன்டோனியோ , ஒன்றுபட்டது மாநிலங்களில் , சிசிலியா சீமோநெல்லி ,

DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor a | ANP Pers Support

DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor a | ANP Pers Support
perssupport.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from perssupport.nl Daily Mail and Mail on Sunday newspapers.

San Antonio , United States , Cecilia Simonelli , Tanjan Fehm , Linda Pavy , Heinrich Heine University , Head Of The Department Gynecology Obstetrics , Us Food Drug Administration , China National Medical Products Administration , Research Use , Menarini Group , Antonio Breast Cancer Symposium , Silicon Biosystems , Menarini Silicon Biosystem , Global Medical Affairs Head , Menarini Silicon , Circulating Tumor Cell , Drug Administration , Metastatic Breast , Tumor Cell Kit , Tumor Phenotyping Reagent , Huntingdon Valley , சான் அன்டோனியோ , ஒன்றுபட்டது மாநிலங்களில் , சிசிலியா சீமோநெல்லி , ஹென்ரிச் ஹெய்ன் பல்கலைக்கழகம் ,